![](https://static.youtibao.com/asksite/comm/pc/images/content_title_q.png)
[单选题]
2019WCLC上公布的SHR1210-III-303研究结果中,卡瑞利珠单抗联合化疗组的ITT人群的中位DoR是?()
A.17.6个月
B.9.9个月
C.11.2个月
D.7.8个月
![](https://static.youtibao.com/asksite/comm/pc/images/content_title_a.png)
查看答案
A.17.6个月
B.9.9个月
C.11.2个月
D.7.8个月
第7题
A.5.68个月
B.6.18个月
C.6.48个月
D.7.12个月
第8题
A.SHR1210-II-201,2019WCLC
B.SHR1210-II-202,2019ASCO
C.SHR1210-III-303,2019WCLC
D.SHR1210-III-303,2019ASCO